# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-552040
Filing Date
2016-04-22
Accepted
2016-04-22 16:13:09
Documents
4
Period of Report
2016-05-31
Effectiveness Date
2016-04-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | d121496ddef14a.htm | DEF 14A | 1170458
2 | GRAPHIC | g121496g30n33.jpg | GRAPHIC | 85657
3 | GRAPHIC | g121496pcpg001.jpg | GRAPHIC | 295693
4 | GRAPHIC | g121496pcpg002.jpg | GRAPHIC | 258954
| Complete submission text file | 0001193125-16-552040.txt |  | 2053930

Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 161586851
SIC: 2834 Pharmaceutical Preparations